Vitamin A Deficiency

Overview


Plain-Language Overview

Vitamin A Deficiency is a condition where the body lacks enough vitamin A, an essential nutrient important for maintaining healthy vision, skin, and immune function. This deficiency primarily affects the eyes, leading to problems with seeing in low light, known as night blindness. It can also cause dryness and damage to the surface of the eye, increasing the risk of infections and even blindness if untreated. The immune system becomes weaker, making it harder for the body to fight off infections. This condition is most common in areas with poor nutrition or malabsorption issues.

Clinical Definition

Vitamin A Deficiency is a disorder characterized by insufficient levels of vitamin A, a fat-soluble vitamin crucial for phototransduction, epithelial cell maintenance, and immune competence. It commonly results from inadequate dietary intake, malabsorption syndromes, or increased requirements during illness. The deficiency leads to impaired synthesis of rhodopsin, causing night blindness, and disrupts epithelial cell differentiation, resulting in xerophthalmia and keratinization of mucous membranes. It also compromises the immune system, increasing susceptibility to infections. Clinically, it is significant due to its potential to cause irreversible blindness and increased morbidity from infectious diseases.

Inciting Event

  • Dietary deficiency due to insufficient intake of vitamin A-rich foods such as liver, dairy, and leafy vegetables.

  • Onset of malabsorption conditions impairing fat-soluble vitamin absorption.

  • Acute infections like measles increasing metabolic demand for vitamin A.

  • Prolonged diarrhea leading to nutrient loss and decreased absorption.

  • Chronic liver injury impairing vitamin A storage and mobilization.

Latency Period

  • Weeks to months of inadequate vitamin A intake before ocular symptoms develop.

  • Variable latency depending on baseline vitamin A stores and severity of deficiency.

  • Rapid onset of symptoms can occur during acute infections in deficient individuals.

  • Progressive worsening of epithelial changes over months without supplementation.

  • Delayed symptom onset in mild deficiency due to hepatic vitamin A reserves.

Diagnostic Delay

  • Nonspecific early symptoms such as night blindness often overlooked or attributed to other causes.

  • Lack of awareness of vitamin A deficiency in developed countries leading to missed diagnosis.

  • Overlap with other ocular diseases causing diagnostic confusion.

  • Limited access to diagnostic testing in resource-poor settings.

  • Failure to recognize systemic signs like xerosis or Bitot spots during physical exam.

Clinical Presentation


Signs & Symptoms

  • Night blindness is the earliest and most characteristic symptom

  • Dry eyes and irritation due to decreased tear production

  • Bitot spots visible on the conjunctiva

  • Photophobia and eye pain in advanced corneal involvement

  • Dry, rough skin with follicular hyperkeratosis

History of Present Illness

  • Progressive difficulty seeing in low light (night blindness) is often the first symptom reported.

  • Dryness and irritation of the eyes with possible conjunctival xerosis and Bitot spots develop over time.

  • Recurrent infections such as respiratory or gastrointestinal infections may be noted.

  • Skin dryness and follicular hyperkeratosis may accompany ocular symptoms.

  • In severe cases, corneal ulceration and keratomalacia can lead to vision loss.

Past Medical History

  • History of malabsorption syndromes such as cystic fibrosis or celiac disease.

  • Chronic liver disease or hepatitis impairing vitamin A metabolism.

  • Previous episodes of measles or other infections increasing vitamin A demand.

  • Long-term use of fat-malabsorbing medications like orlistat or cholestyramine.

  • History of poor dietary intake or malnutrition especially in vulnerable populations.

Family History

  • No direct heritable pattern is associated with vitamin A deficiency.

  • Family members may share dietary habits predisposing to deficiency.

  • Rare genetic disorders affecting retinol metabolism could be relevant but are uncommon.

  • No known familial syndromes specifically linked to vitamin A deficiency.

  • Family history of malabsorption diseases may increase risk in relatives.

Physical Exam Findings

  • Bitot spots on the conjunctiva characterized by foamy, white, triangular patches

  • Xerosis or dryness of the conjunctiva and cornea

  • Keratomalacia, a softening and ulceration of the cornea in severe deficiency

  • Follicular hyperkeratosis of the skin, especially on extensor surfaces

  • Night blindness evidenced by delayed pupillary response in dim light

Diagnostic Workup


Diagnostic Criteria

Diagnosis of vitamin A deficiency is based on clinical findings such as night blindness, xerophthalmia, and characteristic ocular signs including Bitot spots. Serum retinol levels below 0.70 µmol/L confirm deficiency. Additional supportive evidence includes a history of poor dietary intake or malabsorption. Response to vitamin A supplementation can also aid in diagnosis but is not required for confirmation.

Pathophysiology


Key Mechanisms

  • Impaired synthesis of visual pigments due to deficiency of vitamin A leading to night blindness.

  • Epithelial cell metaplasia and keratinization in mucous membranes causing xerophthalmia and Bitot spots.

  • Reduced immune function from impaired mucosal barrier and lymphocyte function increasing infection risk.

  • Defective differentiation of epithelial tissues resulting in dry skin and increased susceptibility to infections.

  • Impaired retinoic acid signaling affecting gene transcription critical for cell growth and differentiation.

InvolvementDetails
Organs

Eye is the primary organ affected, with clinical manifestations including night blindness, xerophthalmia, and keratomalacia.

Liver serves as the main storage site for vitamin A and is critical for maintaining systemic vitamin A homeostasis.

Tissues

Corneal epithelium undergoes keratinization and xerosis in vitamin A deficiency, leading to dryness and potential ulceration.

Conjunctival epithelium shows squamous metaplasia and loss of goblet cells, causing impaired mucous secretion.

Cells

Conjunctival goblet cells produce mucin essential for tear film stability and are impaired in vitamin A deficiency.

Retinal photoreceptor cells require vitamin A derivatives for visual pigment regeneration, critical for night vision.

Chemical Mediators

Retinoic acid acts as a signaling molecule regulating epithelial cell differentiation and immune function.

Rhodopsin is a vitamin A-derived visual pigment in photoreceptors essential for low-light vision.

Treatments


Pharmacological Treatments

  • Vitamin A supplementation

    • Mechanism:
      • Replenishes deficient retinol stores to restore normal epithelial function and vision.

    • Side effects:
      • Hypervitaminosis A

      • Headache

      • Nausea

    • Clinical role:
      • First-line

Non-pharmacological Treatments

  • Dietary improvement with increased intake of vitamin A-rich foods such as liver, dairy products, and orange vegetables.

  • Management of underlying malabsorption or chronic illnesses contributing to deficiency.

Prevention


Pharmacological Prevention

  • Oral vitamin A supplementation in high-risk populations to prevent deficiency

  • Periodic high-dose vitamin A capsules recommended by WHO for children in endemic areas

  • Vitamin A fortification of staple foods in deficient regions

  • Parenteral vitamin A administration in severe malabsorption or acute deficiency

  • Adjunctive vitamin A therapy during measles infection to reduce morbidity and mortality

Non-pharmacological Prevention

  • Dietary diversification to include vitamin A-rich foods such as liver, dairy, and orange vegetables

  • Breastfeeding promotion to provide adequate vitamin A to infants

  • Public health education on nutrition and hygiene to reduce deficiency risk

  • Improved sanitation and infection control to decrease vitamin A depletion from illness

  • Screening programs in at-risk populations to identify early deficiency

Outcome & Complications


Complications

  • Corneal ulceration and keratomalacia leading to permanent blindness

  • Increased susceptibility to infections due to impaired mucosal immunity

  • Xerophthalmia progressing to irreversible blindness if untreated

  • Growth retardation in children due to systemic effects

  • Increased mortality risk especially in children with concurrent infections

Short-term Sequelae Long-term Sequelae
  • Night blindness and impaired dark adaptation

  • Conjunctival xerosis and Bitot spots formation

  • Increased risk of ocular infections such as conjunctivitis

  • Dry, scaly skin with follicular hyperkeratosis

  • Transient immune dysfunction increasing infection risk

  • Permanent blindness from corneal scarring and keratomalacia

  • Chronic xerophthalmia with persistent ocular surface damage

  • Delayed growth and development in pediatric patients

  • Increased lifelong susceptibility to respiratory and gastrointestinal infections

  • Potential irreversible damage to epithelial tissues

Differential Diagnoses


Vitamin A Deficiency versus Zinc Deficiency

Vitamin A Deficiency

Zinc Deficiency

History of inadequate intake or malabsorption of vitamin A-rich foods

History of malabsorption, chronic diarrhea, or inadequate dietary intake of zinc

Low serum retinol levels with normal zinc levels

Low serum zinc levels with normal retinol levels

Night blindness, xerophthalmia, and Bitot spots

Periorificial and acral dermatitis, alopecia, and impaired wound healing

Vitamin A Deficiency versus Sjogren Syndrome

Vitamin A Deficiency

Sjogren Syndrome

More common in children and young adults with nutritional deficiency

Typically middle-aged adults

Dry eyes due to keratinization and xerosis from vitamin A deficiency

Dry eyes and dry mouth due to autoimmune destruction of exocrine glands

Low serum retinol and improvement with vitamin A supplementation

Positive anti-Ro (SSA) and anti-La (SSB) antibodies

Vitamin A Deficiency versus Congenital Night Blindness

Vitamin A Deficiency

Congenital Night Blindness

No genetic inheritance; acquired deficiency

X-linked or autosomal dominant inheritance

Develops after prolonged vitamin A deficiency

Present from birth or early childhood

Normal rod function restored after vitamin A supplementation

Electroretinogram shows absent or reduced rod function

Vitamin A Deficiency versus Keratoconjunctivitis Sicca (Dry Eye Syndrome)

Vitamin A Deficiency

Keratoconjunctivitis Sicca (Dry Eye Syndrome)

Presence of Bitot spots and night blindness

Dryness and irritation without Bitot spots or night blindness

Associated with malnutrition or malabsorption causing vitamin A deficiency

Associated with aging, environmental factors, or autoimmune disease

Improves with vitamin A supplementation

Improves with artificial tears and management of underlying cause

Vitamin A Deficiency versus Hypovitaminosis D

Vitamin A Deficiency

Hypovitaminosis D

Ocular symptoms such as night blindness and xerophthalmia

Bone pain, muscle weakness, and rickets or osteomalacia

Low serum retinol with normal calcium and parathyroid hormone levels

Low serum 25-hydroxyvitamin D with elevated parathyroid hormone

Improves with vitamin A supplementation

Improves with vitamin D and calcium supplementation

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.